Noninferiority testing in clinical trials issues and challenges
"This book focuses on the rationale of choosing the noninferiority (NI) margin as a small fraction of the therapeutic effect of the active control in a clinical trial. It discusses issues of estimating the effect size based on historical placebo control trials of the active control. The book al...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | UnknownFormat |
Sprache: | eng |
Veröffentlicht: |
Boca Raton u.a.
CRC Press
2015
|
Schriftenreihe: | Chapman & Hall/CRC biostatistics series
68 |
Schlagworte: | |
Online Zugang: | Inhaltsverzeichnis |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | "This book focuses on the rationale of choosing the noninferiority (NI) margin as a small fraction of the therapeutic effect of the active control in a clinical trial. It discusses issues of estimating the effect size based on historical placebo control trials of the active control. The book also covers basic concepts related to NI trials, such as essay sensitivity, constancy assumption, discounting, and preservation. Other topics described include patient populations, three-arm trials, and testing equivalence of three or more groups"--Provided by publisher |
---|---|
Beschreibung: | Includes bibliographical references and index |
Beschreibung: | XVII, 190 S. : Ill., graph. Darst. |
ISBN: | 9781466561496 |